AEON Biopharma, Inc.

NYSEAM:AEON Stock Report

Market Cap: US$24.0m

AEON Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AEON?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,424,1976.06%
Institutions2,636,2936.6%
Private Companies3,555,0008.89%
VC/PE Firms5,411,28513.5%
Public Companies6,577,60416.5%
Hedge Funds7,274,91818.2%
General Public12,091,39630.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.6%.

Top Shareholders

Top 25 shareholders own 69.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
Daewoong Co., Ltd.
4,177,604US$2.5m0%no data
9.19%
Atalaya Capital Management LP
3,675,000US$2.2m0%4.01%
9.01%
Polar Asset Management Partners Inc.
3,599,918US$2.2m-2.04%0.08%
8.89%
Priveterra Sponsor, LLC
3,555,000US$2.1m-48.5%no data
8.36%
Blue Owl Capital, Investment Arm
3,341,204US$2.0m0%0.75%
6%
Daewoong Pharmaceutical Co., Ltd
2,400,000US$1.4m0%no data
5.67%
Robert Palmisano
2,265,000US$1.4m0%no data
5.18%
Crown Holdings LLC
2,070,081US$1.2m0%100.0%
1.88%
The Vanguard Group, Inc.
751,343US$450.8k0%no data
0.98%
Formidable Asset Management, LLC
389,782US$233.9k243%0.04%
0.66%
BlackRock, Inc.
265,150US$159.1k-2.63%no data
0.65%
Ikarian Capital, LLC
257,977US$154.8k0%0.04%
0.61%
Geode Capital Management, LLC
243,168US$145.9k30.1%no data
0.42%
Bank of America Corporation, Asset Management Arm
166,600US$100.0k620%no data
0.18%
Marc Forth
69,963US$42.0k0%no data
0.16%
Two Sigma Investments, LP
65,208US$39.1k0%no data
0.16%
The Caprock Group, LLC
62,686US$37.6k0%no data
0.15%
State Street Global Advisors, Inc.
60,950US$36.6k0%no data
0.14%
UBS Asset Management AG
57,635US$34.6k0%no data
0.14%
Boothbay Fund Management, LLC
55,062US$33.0k0%no data
0.13%
Northern Trust Global Investments
51,928US$31.2k0%no data
0.12%
LMR Partners LLP
48,901US$29.3k-11%no data
0.11%
Jost Fischer
43,770US$26.3k0%no data
0.067%
LPL Financial Corporation, Asset Management Arm
26,840US$16.1k0%no data
0.063%
Chad Oh
25,107US$15.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 23:44
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AEON Biopharma, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas TsaoH.C. Wainwright & Co.